About the ARISE-AD Study
A Clinical Study to Evaluate a Potential Treatment for Atopic Dermatitis (Eczema)
The ARISE-AD Study will test the safety and effectiveness of the potential drug ANB032 to reduce the pain, itch, skin irritation, and other symptoms caused by AD.
This study will assess the efficacy of the study drug to:
Reduce the skin irritation and other problems that atopic dermatitis causes for people living with AD
Moderate the overreaction in your body’s immune system that results in atopic dermatitis symptoms
Improve peoples’ overall quality of life
The study drug is a novel treatment that may moderate some of the factors that cause overactive immune responses in patients with atopic dermatitis. Modulating the immune system in this way may provide relief from the irritation, pain, itch, and disruption in everyday activities experienced by so many people.
If you or your loved one suffers from irritation and other painful symptoms of atopic dermatitis, then the ARISE-AD Study may be a good option to explore. Please get in touch with your doctor or the local study team and site to learn more. Check the study finder below for the site closest to you.
The ARISE-AD Study Is Looking for Volunteers With Atopic Dermatitis
About 160 eligible patients with atopic dermatitis will be enrolled at multiple study locations across the United States, Canada, Europe, Australia, and New Zealand.
You are eligible* to participate in the study if:
You are aged 18–65
You have been diagnosed with moderate-to-severe atopic dermatitis (also referred to as eczema) for at least 6 months
You have not found relief despite the use of standard treatments for atopic dermatitis
You are in generally good health besides your atopic dermatitis diagnosis
* Additional criteria for eligibility apply
If study investigators determine you are eligible, your participation may help find a potential treatment option for you and others with atopic dermatitis.
If you participate in the ARISE-AD Study, you will be asked to: **
Provide signed informed consent
Comply with all scheduled clinic visits and study-related procedures
Not take any study-prohibited medications during the trial period
Your participation in the ARISE-AD Study is entirely voluntary, and your information will be confidential. If you change your mind, you can withdraw from the study at any time, for any reason, and without any consequences.
** Additional responsibilities apply
What to Expect During the Study?
The study lasts for about 40 weeks consisting of 15 clinic visits to update on your health status, including:
Screening Period
An initial Screening Period of up to 5 weeks with 1 clinic visit
You will undergo assessments to check if you fully qualify to participate in the study
Treatment Period
A Treatment Period of 12 weeks with 7 clinic visits
At randomization and 6 additional visits, you will receive a dose of either ANB032 or an inactive placebo. Each dose consists of 2 injections under the skin
You or your doctor will not know if you received the active drug or the placebo until after the end of the study
Follow-up Period
A Follow-up Period of 24 weeks with 7 clinic visits
This includes follow-ups to ensure your well-being and measure your response to the doses you received
Beyond the initial screening period, the study lasts for about 36 weeks consisting of 14 clinic visits to update on your health status, including: ***
Routine laboratory tests
Urinalysis
Physical exam
Vital signs
Standard assessments of the severity of atopic dermatitis symptoms
*** Additional assessments apply
See If You Qualify
Find an ARISE-AD Study Site Near You
For additional information and to find the best location for you, please use the site finder map below.
Search Study Site
Enter Your Location
Include Countries In Search:
1. Progressive Clinical Research
Attn: Jamie Renker
1973 Northwest Loop 410, Suite 106, San Antonio, TX 78213
United States
P: 210-614-5557
Primary Investigator
Dr. Mark Lee
Study Coordinator
Jamie Renker
2. North Texas Center for Clinical Research
Attn: Ali Ruble
3880 Parkwood Blvd, Suite 102, Frisco, TX 75034
United States
Primary Investigator
Dr. Timothy Rodgers
Study Coordinator
Ali Ruble
P: 214-618-0220
3. Floridian Research Institute
Attn: Giovanna Fernandez
1021 Ives Dairy Rd, Suite 214, Miami, FL 33179
United States
P: 786-391-1137
Primary Investigator
Dr. Gretel Trullenque
4. Center For Dermatology Clinical Research, Inc.
Attn: Evguenia Vals
2557 Mowry Ave, Suite 25, 34, Fremont, CA 94538
United States
Primary Investigator
Dr. Sunil S. Dhawan
Study Coordinator
Evguenia Vals
P: 510-797-0140 ext 3
5. Wilmington Dermatology Center
WDC Cosmetic and Research PLLC
Attn: Taylor Thompson
710 Military Cutoff Rd, Suite 320, Wilmington, NC 28405
United States
P: 910-256-4350
Primary Investigator
Dr. Rosalyn George
6. Darst Dermatology
Attn: Megha Singh
11301 Golf Links Dr North, Suite 2023, Charlotte, NC 28277
United States
Primary Investigator
Dr. Marc Darst
Study Coordinator
Megha Singh
P: (704) 321-3376 ext 1017
7. Medisearch Clinical Trials
Attn: Heather Jackson
1427 Village Dr , St. Joseph, MO 64506
United States
Primary Investigator
Dr. Melody Stone
Study Coordinator
Heather Jackson
P: 816-364-1515
8. Clinical Science Institute
Attn: Mario Castillo
2001 Santa Monica Blvd., SUITE 1160W & 1185W, Santa Monica, CA 90404
United States
P: 310-828-8887
Primary Investigator
Dr. Yamauchi
Study Coordinator
Mario Castillo
Study Coordinator
Carolyn Ferguson
9. Oregon Medical Research Center
1750 S. Harbor Way, Suite 330, Portland, OR 97201
United States
P: 503-245-1525
Primary Investigator
Dr. Benjamin Ehst
Study Coordinator
Charlie Blauvelt
10. Henry Ford Health System
Department of the Dermatology
Attn: Ashkhen Movsisyan
3031 W. Grand Boulevard, NCO 7208, Detroit, MI 48202
United States
P: (313) 916-2600
Primary Investigator
Dr Stein Gold
11. LCC Medical Research Institute
Attn: Jaikelys Tavel
1150 Northwest 72nd Ave., Suite 620, Miami, FL 33126
United States
P: 305-400-0814
Primary Investigator
Duardo Guerra
12. Tennessee Clinical Research Center
Attn: Jamie Tice
2000 Richard Jones Rd, Suite 223, Nashville, TN 37215
United States
P: 615-383-9660
13. Anthelope Valley Clinical Trials
44453 16th St West, Suite 101, Lancaster, CA 93534
United States
Primary Investigator
Dr. Tan
Study Coordinator
Gabriela Ramirez
P: 661-266-8944
14. First OC Dermatology
Attn: Vanessa Montanez
17271 Brookhurst St , Fountain Valley, CA 92708
United States
Primary Investigator
Dr. Laquer
Study Coordinator
Vanessa Montanez
P: 714-531-2966
15. Advanced Medical Research, PC
Attn: Brittney Ray
5730 Glenridge Dr, Suite T-100, Sandy Springs, GA 30328
United States
Primary Investigator
Dr. Jamie Weisman, M.D.
P: 404-939-9220 x 112
Study Coordinator
Brittney Ray
Study Coordinator
Marie Edwards
16. Reveal Research Institute
Attn: Cristina Martinez
2110 Research Row, Dallas, TX 75235
United States
Primary Investigator
Dr. Abramovitz
Study Coordinator
Alison Tran, MD
P: 972-797-9297, option 2
17. Torrance Clinical Research Institute Inc.
Attn: Mansoreh Afshar
25043 Narbonne Ave., Lomita, CA 90717
United States
Primary Investigator
Dr. Raikhel
Study Coordinator
Mansoreh Afshar
P: 424-203-8982
P: 310-373-8120
18. University of Michigan Hospital
Attn: Meghan Patton
1500 E Medical Center Dr, Ann Arbor, MI 48109
United States
P: 734-936-4000
Primary Investigator
Dr. Johann Eli Gudjonsson, MD, PhD
19. DS Research of Southern Indiana
Attn: Kristi Doblado
1005 East Lewis And Clark Pkwy., Clarksville, IN 47129
United States
@dsresearchtrials
P: 502-373-2849
Primary Investigator
Dr. Vissing
20. Southern Indiana Clinical Trials
Attn: Christy Nardi
1813 State Street, Suite 200, New Albany, IN 47150
United States
P: 502-373-8133
Primary Investigator
Dr. Megan Landis, Board-Certified Dermatologist
Study Coordinator
Christy Nardi
21. Dermatologists of Southwest Ohio
Attn: Erica Mihaltian
6110 Radio Way, Mason, OH 45040
United States
Primary Investigator
Dr. Rocco T. Serrao, MD
Study Coordinator
Erica Mihaltian
P: 513-701-5526
22. Advanced Specialty Research LLC
200 North 3rd Street, Suite 110, Boise, ID 83702
United States
P: 208-906-1600
Primary Investigator
Dr. Bill Laitinen, MD
Study Coordinator
Jennifer Poralla
23. ActivMed Practices & Research of Alcanza
421 Merrimack St., Methuen, MA 01844
United States
P: 978-451-0831
Primary Investigator
Dr. Mancuso
24. Premier Clinical Research
324 S Sherman St, a2, Spokane, WA 99202
United States
P: 509-343-3710
Primary Investigator
Dr. William Werschler
Study Coordinator
Celeste Gray
E: cgray@premierclinicalresearch.com
Study Coordinator
Heather Berg
25. Columbus Clinical Services
110 NW 27th Ave, Miami, FL 33125
United States
P: 305-631-6991
Primary Investigator
Dr. Armando Pineda-Velez
Study Coordinator
Bertha M Cano
26. R&R Research
8700 W Flagler St., Suite 105, Miami, FL 33174
United States
P: 305-767-9151
Primary Investigator
Dr. Carlos Ricotti
27. International Research Partners
3042 Northwest 82nd Ave. , Doral, FL 33122
United States
P: 305-468-9455
Primary Investigator
Luis Aponte
28. Velocity Clinical Research
5326 O'Donovan Dr., Baton Rouge, LA 70808
United States
P: 225-768-2850
29. Revival Research Institute
Navya Kamath
1575 West Big Beaver Road, Suite C10, Troy, MI 48084
United States
P: 248-590-0298
Primary Investigator
Dr. Ali Moiin
Study Coordinator
Latoya Simmons
30. Oakland Hills Dermatology
3400 Auburn Road, Suite 100, Auburn Hills, MI 48326
United States
P: 248-858-2255
Primary Investigator
Dr. Christofer Buatti, D.O
Study Coordinator
Tricia Swineford
31. Core Healthcare Group
17150 Norwalk Boulavard, Suite 102, Cerritos, CA 90703
United States
P: 562-924-8880
Primary Investigator
Dr. Francisco L. Badar
Study Coordinator
Chistine Cabrera
32. R&H Clinical Research
23215 Red River Drive, Katy, TX 77494
United States
P: 832-886-3275
Primary Investigator
Dr. Syed V. Ahmed
Study Coordinator
Denise Rodriguez
P: 713-367-2791
33. Apex Clinical Trials
4651 Van Dyke Road, Lutz, FL 33558
United States
P: 813-321-1786
Primary Investigator
Dr. Christopher Ewanowski
Study Coordinator
Jennifer Gabriel
P: 813-321-1786 x1796
34. Inquest Clinical Research
1690 West Baker Road, Suite B, Baytown, TX 77521
United States
P: 832-641-8718
Primary Investigator
Dr. Haider Afzal, MD
Study Coordinator
Naheed Mehkri
P: 832-606-2053
35. Cura Clinical Research
1064 North Ventura RD, Oxnard, CA 93030
United States
Primary Investigator
Dr. Michael Lin
Study Coordinator
Jamie Goodnight
P: 833-525-2872 ext. 103
36. DermEffects - Dr Wei Jing Loo
Attn: Christina Craig
1560 Hyde Park Rd, London, ON N6H 5L5
Canada
P: 519-204-6868
Primary Investigator
Dr. Loo
Study Coordinator
Christina Craig
37. SimcoDerm Medical and Surgical Dermatology Center
Attn: Ramin Eshtiaghi
5 Quarry Ridge Rd, Suite 105, Barrie, ON L4M 7G1
Canada
P: 705-503-6331
Primary Investigator
Dr. Maryam Shayesteh Alam
38. North Bay Dermatology Centre
Attn: Tiffany Ellacott
500 Cassells St, North Bay, ON P1B 3Z7
Canada
39. Enverus Medical Reseaech
Attn: Reena Tut-Parhar
13737 96 Ave, Surrey, BC V3V 0C6
Canada
P: 604 495 8278
40. Kingsway Dermatology & Cosmetic Centre
Attn: Poornima Kamble
1243 Islington Ave, Suite 1000, Etobicoke, ON M8X 1Y9
Canada
Primary Investigator
Dr. Marnie E. Fisher
Study Coordinator
Poornima Kamble
P: 416-231-0100 ext 212
41. The Centre for Dermatology
Attn: Sarah Dyalsingh
312 Hwy. 7 East, Richmond Hill, ON L4B 1A5
Canada
Primary Investigator
Dr. Mani Raman
Study Coordinator
Sarah Dyalsingh
P: (905) 889-2019 x6
42. East Sydney Doctors
102 Burton Street , Darlinghurst, NSW 2010
Australia
Primary Investigator
Dr. Baker
Study Coordinator
Eimear Byrne
P: 02 9332 2531
43. LEPL "The First University clinic of Tbilisi State Medical University"
N4 Gudamakari str., Tbilisi , 0141
Georgia
Primary Investigator
Matoshvili
Study Coordinator
Medea Jgarkava
P: +995 599890052
44. LLC Aversi Clinic
No 27b, Vazha-Pshavela ave., Tbilisi, 0160
Georgia
45. LTD "Acad. N.Kipshidze Central University Clinic"
N 29 Vazha-Pshavela Ave., Tbilisi, 0160
Georgia
Primary Investigator
Leonidze
Study Coordinator
Maia Kokaia
P: +995 597124477
46. LLC "Medi Club Georgia"
N22a Tashkenti str., #22 Panjikidze str., (Former Budapeshti str.), Tbilisi, 0160
Georgia
Primary Investigator
Buchukuri
Study Coordinator
Asmat Narsia
P: +995 597505059
47. LTD "Israeli-Georgian Medical Research clinic Helsecore"
N 13g, Tevdore Mgvdeli str., Tbilisi, 0112
Georgia
48. J.S.C. Curatio
31, Otar Lortkipanidze str., Tbilisi, 0114
Georgia
Primary Investigator
Datuashvili
Study Coordinator
Neli Bakuradze
P: +995 5999023 54
49. LLC "Davit Abuladze Georgia-Italian clinic"
N39a, Paliashvili str., Tbilisi, 0179
Georgia
Primary Investigator
Kobakhidze
Study Coordinator
Tinatin Shaishmelashvili
P: +995 5585075 55
50. Dermoklinika Centrum Medyczne
Al Kosciuszki 93, Lodz, 90-436
Poland
51. Tomasz Blicharski Lubelskie Centrum Diagnostyczne
Ul. Drewniana 61, Świdnik , 21-040
Poland
52. Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska
Śliczna 13, Wrocław , 50-566
Poland
Primary Investigator
Szepietowski
Study Coordinator
Katarzyna Matusiak
P: +48 514 755 505
53. MICS Centrum Medyczne Warszawa
ul. Wronia 53 lok. B10, Warszawa, 00-874
Poland
Primary Investigator
Kolinek
Study Coordinator
Kacper Marciniak
P: +48 786 112 990
54. Diamond Clinic Sp Zoo
S. Rogozinskiego 6/U3, Krakow, 31-559
Poland
55. High-Med Przychodnia Specjalistyczna
Kasprowicza 27/2, Warszawa, 01-817
Poland
Primary Investigator
Bystrzanowska
Study Coordinator
Agata Gora
P: +48 501 782 261
56. Uniwersyteckie Centrum Kliniczne, Department of Dermatology, Venereology and Allergology
Gdański Uniwersytet Medyczny, Katedra i Klinika Dermatologii, Wenerologii i Alergologii Sekretariat
ul. Smoluchowskiego 17, Gdańsk, 80-214
Poland
Primary Investigator
Nowicki
Study Coordinator
Agnieszka Grabowska
P: +48 58 584 40 10
57. Klinika Dermatologii Uniwersytecki Szpital Kliniczny Im. F. Chopina In Rzeszów
Ul. Szopena 2, Rzeszów , 35-055
Poland
58. Vitamed Gałaj i Cichomski sp.j.
ul. Kościuszki 35, Bydgoszcz, 85-079
Poland
Primary Investigator
Krzyżynska-Malinowska
Study Coordinator
Rafal Cichomski
P: +48 665 102 401
59. Laser Clinic civil partnership dr Tomasz Kochanowski dr Andrzej Krolicki
Al. Piastów 65/U5, Szczecin, 70-332
Poland
Primary Investigator
Turek-Urasińska
Study Coordinator
Paulina Klen
P: +48 666 400 151
60. A-Derm-Serwis
ul. Waszyngtona 42/3, Częstochowa, 42-217
Poland
Primary Investigator
Kusiba-Strazynska
Study Coordinator
Monika Fafrowicz
P: +48 504 251 231
61. dermMedica Sp. Z.o.o.
ul. Krzysztofa Kolumba 6, Wroclaw, 51-503
Poland
Primary Investigator
Weglovska
62. ClinMedica Research Ltd.
Ogrodowa 21/23, Skierniewice, 96-100
Poland
Primary Investigator
Urban
Study Coordinator
Agnieszka Sas-Grzelecka
P: +48 609 702 525
63. ETG WARSZAWA Ltd.
Ul. Wynalazek 4, Warsaw, 02-677
Poland
Primary Investigator
Zegadlo-Mylik
Study Coordinator
Aleksandra Zajac
P: +48 575 000 749
64. Praglandia s.r.o.
Ostrovskeho 253/3, Prague 5, 150 00
Czechia
Primary Investigator
Andrea Vocilkova
Study Coordinator
Nicole Frankova
P: +420 608052214
65. Clintrial, s.r.o
Počernická 16, Praha 10, 130 00
Czechia
Primary Investigator
Otakar Komarek
Study Coordinator
Zuzana Procházková
P: +420274778577
66. Pratia Pardubice a.s.
trida Miru 2800, Pardubice, 530 02
Czechia
Primary Investigator
Vaneckova
Study Coordinator
Pavel Palúch
P: +420608518311
67. Kozni ordinace
Bolzanova 1604/7, Prague 1, 110 00
Czechia
Primary Investigator
Petr Arenberger
Study Coordinator
Paula Kastierova
P: +420 735750955